Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
9.90
+0.03 (0.25%)
Oct 17, 2025, 2:15 PM EDT - Market open
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $3.11 billion as of October 17, 2025. Its market cap has increased by 15.40% in one year.
Market Cap
3.11B
Enterprise Value
5.61B
1-Year Change
15.40%
Ranking
Category
Stock Price
$9.90
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $3.11B, a decrease of -46.05%. That is a compound annual growth rate of -7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 3.10B | 26.32% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |